We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-7.65%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$271B
AUM Growth
-$17.9B
Cap. Flow
+$8.73B
Cap. Flow %
3.23%
Top 10 Hldgs %
15.47%
Holding
7,097
New
161
Increased
2,856
Reduced
3,285
Closed
377

Sector Composition

Rank Sector Weight
1 Healthcare 9.07%
2 Financials 8.9%
3 Technology 7.48%
4 Consumer Discretionary 7.12%
5 Communication Services 7.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFA
5151
DELISTED
POWERSHARES GLB EXCH TRD FD DYNAMIC DEVEL INTL OPPORT PORT
PFA
$145K ﹤0.01%
7,576
-4,857
-39% -$93K
MESG
5152
DELISTED
XURA INC COM (DE)
MESG
$144K ﹤0.01%
6,450
+5,127
+388% +$103K
ZYNE
5153
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$143K ﹤0.01%
+10,011
New +$246K
TLRA
5154
DELISTED
Telaria, Inc.
TLRA
$143K ﹤0.01%
77,080
-36,558
-32% -$83.1K
SQNM
5155
DELISTED
SEQUENOM INC NEW
SQNM
$143K ﹤0.01%
82,279
-260,180
-76% -$637K
CPRX
5156
DELISTED
Catalyst Pharmaceutical
CPRX
$142K ﹤0.01%
47,308
-323,205
-87% -$1.39M
CRMD icon
5157
CorMedix
CRMD
$639M
$142K ﹤0.01%
14,277
+1,910
+15% +$29.5K
GF
5158
New Germany Fund
GF
$188M
$142K ﹤0.01%
9,853
-11,936
-55% -$180K
ADMS
5159
DELISTED
Adamas Pharmaceuticals
ADMS
$142K ﹤0.01%
8,497
-3,474
-29% -$79K
IVTY
5160
DELISTED
Invuity, Inc
IVTY
$142K ﹤0.01%
10,164
+10,163
+1,016,300% +$133K
KUST
5161
Kustom Entertainment Inc
KUST
$859K
0
GLF
5162
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$141K ﹤0.01%
23,172
-42,486
-65% -$362K
CYAD
5163
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$140K ﹤0.01%
3,347
+2,847
+569% +$147K
ROYT
5164
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$140K ﹤0.01%
67,774
+3,956
+6% +$11.3K
MKC.V icon
5165
McCormick & Company Voting
MKC.V
$14.5B
$139K ﹤0.01%
3,388
PYN
5166
DELISTED
PIMCO New York Municipal Income Fund III
PYN
$139K ﹤0.01%
14,127
TBBK icon
5167
The Bancorp
TBBK
$2.82B
$139K ﹤0.01%
18,270
+10,688
+141% +$89.2K
FAUS
5168
DELISTED
First Trust Australia AlphaDEX Fund
FAUS
$139K ﹤0.01%
5,476
+21
+0.4% +$582
UDF
5169
DELISTED
UNITED DEV FDG IV COM SHS OF BENE INT (TX)
UDF
$139K ﹤0.01%
7,858
+2,902
+59% +$51.5K
FLNT
5170
Fluent
FLNT
$132M
$138K ﹤0.01%
+3,109
New +$153K
EVJ
5171
DELISTED
Eaton Vance New Jersey Municipal Income Trust
EVJ
$138K ﹤0.01%
11,500
CAS
5172
DELISTED
A M Castle & Co
CAS
$138K ﹤0.01%
62,102
+36,338
+141% +$127K
PSR icon
5173
Invesco Active US Real Estate Fund
PSR
$59.9M
$137K ﹤0.01%
1,999
+438
+28% +$30.6K
IBCC
5174
DELISTED
iShares iBonds Mar 2018 Term Corporate ex-Financials ETF
IBCC
$137K ﹤0.01%
5,544
+364
+7% +$9.04K
ENZY
5175
DELISTED
Enzymotec Ltd
ENZY
$137K ﹤0.01%
15,198
+6,459
+74% +$57.6K

Similar funds

Morgan Stanley's Q3 2015 Portfolio in Review

As of Q3 2015, Morgan Stanley held 7,097 positions worth $271B, down 6.2% from $289B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley deployed $8.73B of net new capital in Q3 2015, opening 161 new positions and adding to 2,856 existing holdings. Its largest new stake was Kraft Heinz: 7,552,361 shares worth $533M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, down from 11% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was AbbVie, an estimated $1.44B trimmed.

  • Morgan Stanley's largest Q3 2015 buy was Kraft Heinz: 7,552,361 shares worth $533M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $10.5B increase.
  • Morgan Stanley's biggest Q3 2015 reduction was AbbVie, cutting an estimated $1.44B.
  • Morgan Stanley fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $458M.
  • Morgan Stanley's ten largest holdings make up 15% of its $271B portfolio in Q3 2015.
  • Morgan Stanley opened 161 new positions and closed 377 in Q3 2015.
  • Morgan Stanley's portfolio value fell 6.2% quarter-over-quarter to $271B.

Based on Morgan Stanley's 13F filing for Q3 2015, filed 9 Nov 2015.